Latest News
WHAM, BrightFocus Foundation Join Together to Promote Increased Funding for Women-Focused Alzheimer’s Research.
Learn about how researchers were able to predict the onset of Alzheimer’s disease (AD) using MRI.
Learn about a new 3D model of the neurovascular unit which helps to study how the vasculature contributes to neurodegenerative disease.
Learn about how researchers made a more accurate model of Alzheimer's disease using skin cells.
FDA approves of new Alzheimer's drug.
Learn about how a test allows clinicians to accurately detect signs of Alzheimer's Disease from a single blood draw.
A study of 131 older adults shows that driving behavior may be a good way to identify Alzheimer’s disease before other symptoms appear.
Tau is a protein that misfolds in Alzheimer’s disease, causing it to accumulate and aggregate in the brain, contributing to cognitive decline. Mice engineered to lack tau are protected from neuronal damage, and when levels of tau are reduced in mouse models of Alzheimer’s, their memory improves. Therefore, reducing tau may be a good therapeutic option for AD.
Dr. Croft, Dr. Golde, and colleagues used a method, consisting of thin sections of brain tissue from mice that were kept alive for months in cell culture dishes, to model how tau accumulates and changes in the brain. Their results showed that brain tissue containing the normal, nonpathological versions of tau do not form inclusions. The researchers were surprised to find that these tau inclusions weren’t just static clumps of protein.
In a study of more than 1,200 people, researchers show that individuals with higher levels of saturated fats in their blood are more likely to develop dementia, including Alzheimer’s disease.
